FindTrial
Sign In

Effect of serratus anterior block with bupicacaine 0.25% after breast surgeries

A Comparative Study of Bupicacaine 0.25% Versus Bupicacaine 0.25% with Dexamethasone 4mg in Ultrasound Guided Serratus Anterior Plane Block for Post Operative Analgesia in Unilateral Breast Surgeries - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065592
Enrollment
100
Registered
2024-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Control Intervention1: Nil: Nil

Sponsors

Krishna K
Lead Sponsor
Shashikumar P
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: BMI of less than 35kg/m2, patients undergoing unilateral breast surgeries

Exclusion criteria

Exclusion criteria: patient allergic to local anaesthetic, diabetic, bleeding disorder, local infection

Design outcomes

Primary

MeasureTime frame
To compare the duration of post operative analgesia between bupivacaine 0.25% versus bupivacaine 0.25% with dexamethasone 4mg. Timepoint: 24hours—

Secondary

MeasureTime frame
Post Operative ComplicationTimepoint: 24 hours—

Countries

India

Contacts

Public ContactShashikumar P

Mandya institute of medical sciences

drkris66@gmail.com9448046220

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026